Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CLDI

Calidi Biotherapeutics Inc

May 11 • 04:00PM ET

0.1985

-0.0120 -5.70 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: PSTV LIXT IMNN BCTX BCDA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.96	Insider Own	10.23%	Shs Outstand	10.90M	Perf Week	-6.37%
Market Cap	2.16M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.08%	Shs Float	9.78M	Perf Month	-22.61%
Enterprise Value	-0.98M	PEG	-	EPS next Q	-	Inst Own	6.51%	Short Float	31.07%	Perf Quarter	-75.95%
Income	-25.58M	P/S	-	EPS this Y	-	Inst Trans	2.63%	Short Ratio	0.81	Perf Half Y	-88.04%
Sales	0.00M	P/B	0.38	EPS next Y	-	ROA	-222.05%	Short Interest	3.04M	Perf YTD	-83.03%
Book/sh	0.52	P/C	0.38	EPS next 5Y	-	ROE	-966.52%	52W High	19.20 -98.97%	Perf Year	-96.40%
Cash/sh	0.52	P/FCF	-	EPS past 3/5Y	74.50% -	ROIC	-532.12%	52W Low	0.19 3.71%	Perf 3Y	-99.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.71% 11.38%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	84.28%	Oper. Margin	-	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.59	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	32.44	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.59	EPS Q/Q	76.27%	SMA20	-14.33%	Beta	1.36	Target Price	120.00
Payout	-	Debt/Eq	0.68	Sales Q/Q	-	SMA50	-34.93%	Rel Volume	0.39	Prev Close	0.21
Employees	29	LT Debt/Eq	0.28	Earnings	Mar 27 AMC	SMA200	-86.88%	Avg Volume	3.75M	Price	0.20
IPO	Nov 01, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	2,405,470	Change	-5.70%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)